Latica

AI-based Data Collaboration Platform for the Healthcare Community

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in March 2019 by Omer Dror, Robert Eisdorfer, and Ofir Farchy, Latica operates with 11–50 employees. The company has raised a total of $12 million across four funding rounds from seven investors, with MizMaa Ventures leading one of the rounds.

Business overview

Latica, formerly known as Lynx.MD, provides an AI-based data collaboration platform designed for the healthcare community. The company's core technology enables pharmaceutical, life sciences, and AI companies to securely access sensitive, real-world patient data while preserving privacy. By partnering with healthcare provider organizations, Latica facilitates data licensing opportunities, augmenting their revenue streams. The platform currently hosts data from over 400 million doctor visits, with an initial focus on gastroenterology, ENT, and allergy spaces, and operates within the Digital Healthcare sector, utilizing Artificial Intelligence and Machine Learning.

Strategic signal

Latica is actively expanding its strategic partnerships and technological offerings to enhance real-world data utilization in healthcare. In July 2024, the company forged an alliance with Schweiger Dermatology to advance dermatology research, following a series of collaborations in May 2024 with New York Gastroenterology Associates and Unio Health Partners to expand its GI data ecosystem. This consistent pattern of partnerships and product launches, such as the Chart Abstraction AI in March 2024, signals a strong focus on market penetration and product development, aiming to solidify its position as a leader in secure healthcare data collaboration.

Log in to access full profile

Company Intelligence Q&A

What is Latica's primary focus in the healthcare sector?
Latica's primary focus is on enabling secure and privacy-preserving access to sensitive real-world patient data for pharmaceutical, life sciences, and AI companies, leveraging an AI-based data collaboration platform.
What was a key strategic partnership for Latica in July 2024?
In July 2024, Latica, then operating as Lynx.MD, formed a strategic alliance with Schweiger Dermatology to advance dermatology research using real-world data.
What new AI-powered product did Latica launch in March 2024?
In March 2024, Latica, operating as Lynx.MD, launched Chart Abstraction AI for unstructured medical data.
Log in to access full profile